Tissue factor pathway inhibitor (TFPI) is an essential protein that plays a vital part in controlling blood clotting, mainly through its two forms, TFPI-1 and TFPI-2, with TFPI-1 being the main controller. This protein helps prevent clot formation by blocking factor VIIa and factor Xa, which is important for avoiding thrombosis and sustaining hemostatic equilibrium. Importantly, reduced concentrations of TFPI have been associated with a heightened likelihood of venous thromboembolism and heart attacks. Evaluating TFPI levels is intricate, as different tests provide varying outcomes affected by method discrepancies. Furthermore, genetics, age, cholesterol levels, and certain health issues can influence TFPI concentrations. Precise measurement of TFPI is essential for clarifying its function in coagulation mechanisms and for creating methods to avert unnecessary clot formation in medical settings.